KR20250162620A - 관절증 치료용 조성물 - Google Patents
관절증 치료용 조성물Info
- Publication number
- KR20250162620A KR20250162620A KR1020257035087A KR20257035087A KR20250162620A KR 20250162620 A KR20250162620 A KR 20250162620A KR 1020257035087 A KR1020257035087 A KR 1020257035087A KR 20257035087 A KR20257035087 A KR 20257035087A KR 20250162620 A KR20250162620 A KR 20250162620A
- Authority
- KR
- South Korea
- Prior art keywords
- medium
- pharmaceutical composition
- protein
- composition
- osteoarthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023047351 | 2023-03-23 | ||
| JPJP-P-2023-047351 | 2023-03-23 | ||
| PCT/JP2024/011521 WO2024195878A1 (ja) | 2023-03-23 | 2024-03-22 | 関節症治療用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20250162620A true KR20250162620A (ko) | 2025-11-18 |
Family
ID=92842178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020257035087A Pending KR20250162620A (ko) | 2023-03-23 | 2024-03-22 | 관절증 치료용 조성물 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPWO2024195878A1 (https=) |
| KR (1) | KR20250162620A (https=) |
| CN (1) | CN121398830A (https=) |
| WO (1) | WO2024195878A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102056172B1 (ko) * | 2017-12-06 | 2019-12-16 | 주식회사 디자인셀 | 줄기세포 유래 엑소좀 함유 배양액을 유효성분으로 포함하는 관절염의 예방 또는 치료용 조성물 |
| TWI722400B (zh) * | 2019-03-18 | 2021-03-21 | 佛教慈濟醫療財團法人 | 間質幹細胞之胞外泌體及其用途 |
| JP7371975B1 (ja) * | 2022-09-27 | 2023-10-31 | セルソース株式会社 | 細胞外小胞の製造方法及び細胞外小胞含有組成物 |
-
2024
- 2024-03-22 JP JP2025508627A patent/JPWO2024195878A1/ja active Pending
- 2024-03-22 CN CN202480020996.4A patent/CN121398830A/zh active Pending
- 2024-03-22 WO PCT/JP2024/011521 patent/WO2024195878A1/ja not_active Ceased
- 2024-03-22 KR KR1020257035087A patent/KR20250162620A/ko active Pending
Non-Patent Citations (1)
| Title |
|---|
| 비특허문헌 1: Thery, C., et al., Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles, 2018. 7(1): p.1535750. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN121398830A (zh) | 2026-01-23 |
| JPWO2024195878A1 (https=) | 2024-09-26 |
| WO2024195878A1 (ja) | 2024-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102144593B1 (ko) | 인간줄기세포 유래 엑소좀을 포함하는 세포 배양용 무혈청 배지 조성물 | |
| Las Heras et al. | Extracellular vesicles from hair follicle-derived mesenchymal stromal cells: isolation, characterization and therapeutic potential for chronic wound healing | |
| Yang et al. | Effects of human umbilical cord mesenchymal stem cell-derived exosomes in the rat osteoarthritis models | |
| Chai et al. | Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats | |
| KR102124837B1 (ko) | 기질 줄기 세포 | |
| KR20250135331A (ko) | 중간엽줄기세포 유래 세크레톰의 제조 및 사용 방법 | |
| US20150190429A1 (en) | Use of Preparations Comprising Exosomes Derived From Mesenchymal Stem Cells (MSCs) in the Prevention and Therapy of Inflammatory Conditions | |
| Miguez et al. | Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease | |
| KR20230035517A (ko) | 동결건조 중간엽 줄기세포 유래 세크레톰 및 이의 용도 | |
| EP3426267A1 (en) | Uses of dental pulp stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease | |
| Hanai et al. | Small extracellular vesicles derived from human adipose‐derived mesenchymal stromal cells cultured in a new chemically‐defined contaminate‐free media exhibit enhanced biological and therapeutic effects on human chondrocytes in vitro and in a mouse osteoarthritis model | |
| Mantripragada et al. | Improved biological performance of human cartilage-derived progenitors in platelet lysate xenofree media in comparison to fetal bovine serum media | |
| KR20230074475A (ko) | 골수-유래 중간엽 줄기 세포로부터의 미세소포를 사용한 치료의 조성물 및 방법 | |
| KR101520531B1 (ko) | 편도줄기세포를 이용하여 부갑상선 호르몬을 생산하는 방법 | |
| WO2019031729A2 (ko) | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 비알콜성 단순 지방간 또는 비알콜성 지방간염의 개선 용도 | |
| US12239670B2 (en) | Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease | |
| KR20250162620A (ko) | 관절증 치료용 조성물 | |
| Bunn et al. | Mouse TH2 cell extracellular vesicles promote eosinophil survival through the surface cytokine cargo IL-3 | |
| WO2025049883A1 (en) | Compositions and methods for treating a disease or disorder associated with senescence | |
| US20220193141A1 (en) | Compositions comprising stem cells expressing mesenchymal and neuronal markers and uses thereof to treat neurological disease | |
| WO2019083201A2 (ko) | 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 신장 기능 개선 용도 | |
| Sato et al. | Conditioned media of stem cells from human exfoliated deciduous teeth contain factors related to extracellular matrix organization and promotes corneal epithelial wound healing | |
| KR20220068148A (ko) | 역분화 줄기세포 유래 중간엽 줄기세포로부터 분리된 엑소좀의 제조방법 및 이의 용도 | |
| KR102926380B1 (ko) | 줄기세포 유래 엑소좀의 제조방법, 엑소좀 및 이를 포함하는 조성물 | |
| MOHAMED et al. | The role of stem cells on the ovarian failure induced by busulfan in female albino rat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| Q12 | Application published |
Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE) |